Neuralink, Elon Musk’s brain-implant company, said it received approval from the Food and Drug Administration to conduct human clinical trials.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
minute read
Neuralink, Elon Musk’s brain-implant company, said it received approval from the Food and Drug Administration to conduct human clinical trials.
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.